OI Sciences is looking to out-license its portfolio of hospital product dossiers to interested Companies around the world, with the exception of the UK market. The companies portfolio
of products include improved preparations of small molecules,
differentiated by new presentations and/or improved packaging.

OI Sciences is involved in further partnerships for new technology aimed at delivering further improvements in the preparations of existing small molecules.

For Amiodarone information click here >>

For Fluconazole information click here >>

For further product information click here >>